Table 1.
Summary of the anti-infective strategies (I) antibiotic prophylaxis, (II) G-CSF support, and (III) no prophylaxis.
| Variable | (I) Antibiotic Prophylaxis | (II) G-CSF Support | (III) No Prophylaxis |
|---|---|---|---|
| Period A.D. | March 2016–January 2017 | March 2017–July 2018 | January 2017–March 2017 |
| Ciprofloxacin 500 mg or cotrimoxazole 960 mg twice a day | yes | no | no |
| Filgrastim 5 μg/kg of BW daily until leukocytes > 2/nL | no | yes | no |
| PCP prophylaxis with cotrimoxazole 960 mg thrice weekly | not uniform * | yes | no |
| Acyclovir 400 mg twice a day | yes | yes | yes |
* Patients receiving antibiotic prophylaxis with ciprofloxacin 500 mg twice a day had no PCP-prophylaxis. Abbreviations: BW, body weight; PCP, pneumocystis pneumonia.